One of the most frequent cancers in women is breast cancer, and in the year 2022, approximately 287,850 new cases have been diagnosed. From them, 43,250 women died from this cancer. An early diagnosis of this cancer can help to overcome the mortality rate. However, the manual diagnosis of this cancer using mammogram images is not an easy process and always requires an expert person. Several AI-based techniques have been suggested in the literature. However, still, they are facing several challenges, such as similarities between cancer and non-cancer regions, irrelevant feature extraction, and weak training models. In this work, we proposed a new automated computerized framework for breast cancer classification. The proposed framework improves the contrast using a novel enhancement technique called haze-reduced local-global. The enhanced images are later employed for the dataset augmentation. This step aimed at increasing the diversity of the dataset and improving the training capability of the selected deep learning model. After that, a pre-trained model named EfficientNet-b0 was employed and fine-tuned to add a few new layers. The fine-tuned model was trained separately on original and enhanced images using deep transfer learning concepts with static hyperparameters’ initialization. Deep features were extracted from the average pooling layer in the next step and fused using a new serial-based approach. The fused features were later optimized using a feature selection algorithm known as Equilibrium-Jaya controlled Regula Falsi. The Regula Falsi was employed as a termination function in this algorithm. The selected features were finally classified using several machine learning classifiers. The experimental process was conducted on two publicly available datasets—CBIS-DDSM and INbreast. For these datasets, the achieved average accuracy is 95.4% and 99.7%. A comparison with state-of-the-art (SOTA) technology shows that the obtained proposed framework improved the accuracy. Moreover, the confidence interval-based analysis shows consistent results of the proposed framework.
Currently, the improvement in AI is mainly related to deep learning techniques that are employed for the classification, identification, and quantification of patterns in clinical images. The deep learning models show more remarkable performance than the traditional methods for medical image processing tasks, such as skin cancer, colorectal cancer, brain tumour, cardiac disease, Breast cancer (BrC), and a few more. The manual diagnosis of medical issues always requires an expert and is also expensive. Therefore, developing some computer diagnosis techniques based on deep learning is essential. Breast cancer is the most frequently diagnosed cancer in females with a rapidly growing percentage. It is estimated that patients with BrC will rise to 70% in the next 20 years. If diagnosed at a later stage, the survival rate of patients with BrC is shallow. Hence, early detection is essential, increasing the survival rate to 50%. A new framework for BrC classification is presented that utilises deep learning and feature optimization. The significant steps of the presented framework include (i) hybrid contrast enhancement of acquired images, (ii) data augmentation to facilitate better learning of the Convolutional Neural Network (CNN) model, (iii) a pre‐trained ResNet‐101 model is utilised and modified according to selected dataset classes, (iv) deep transfer learning based model training for feature extraction, (v) the fusion of features using the proposed highly corrected function‐controlled canonical correlation analysis approach, and (vi) optimal feature selection using the modified Satin Bowerbird Optimization controlled Newton Raphson algorithm that finally classified using 10 machine learning classifiers. The experiments of the proposed framework have been carried out using the most critical and publicly available dataset, such as CBIS‐DDSM, and obtained the best accuracy of 94.5% along with improved computation time. The comparison depicts that the presented method surpasses the current state‐of‐the‐art approaches.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.